Cochlear | COH - Ordinary Share Capital


Cochlear reported AUD65.4M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Ansell USD 142.94M 885.26M Dec/2025
Cochlear AUD 65.4M 1.12B Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Fisher Paykel Healthcare NZD 587.25M 1.35M Dec/2025
Healius AUD 2.6B 100K Dec/2024
Integral Diagnostics AUD 335.09M 1.07M Jun/2024
Mayne Pharma AUD 81.25M 0 Jun/2025
Mesoblast USD 1.29B 8.58M Dec/2025
Monash IVF AUD 389.63M 117.15M Dec/2025
Nanosonics AUD 303.35M 188.61M Dec/2025
Polynovo AUD 690.84M 991 Dec/2025
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
Regis Healthcare AUD 302.36M 1.11M Dec/2025
ResMed USD 145.66M 279.42K Dec/2025
Sigma Healthcare AUD 11.5B 9.93B Dec/2025
Somnomed AUD 74.27M 0 Jun/2023
Sonic Healthcare AUD 4.15B 467K Dec/2024
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025